National Pharmaceutical Pricing Authority brings 42 non-scheduled cancer drugs under price control, caps trade margin at 30%
Currently, 57 anti-cancer drugs are under price control as scheduled formulations
The post National Pharmaceutical Pricing Authority brings 42 non-scheduled cancer drugs under price control, caps trade margin at 30% appeared first on Firstpost.